|
|
Other links at Articles > Cardiology |
| 2. |
FDA Safety Changes: Gleevec, Keppra, Neupogen
|
|
|
The FDA has approved revisions to the safety labeling for imatinib mesylate tablets (Gleevec), levetiracetam injection (Keppra), and filgrastim injection (Neupogen). Medscape Medical News
|
|
|